NEUROCRINE BIOSCIE earnings per share and revenue

NB3 earnings per share for the last quarter are 0.91 CHF whereas the estimation was 1.46 CHF which accounts for -37.72% surprise. Company revenue for the same period amounts to 570.08 M CHF despite the estimated figure of 571.67 M CHF. Estimated earnings per share for the next quarter are 0.79 CHF, and revenue is expected to reach 560.28 M CHF. Also watch annual changes over time to get a bigger picture of NB3 earnings per share and revenue dynamics.